Literature DB >> 15536151

The Corfu deltabeta thalassemia deletion disrupts gamma-globin gene silencing and reveals post-transcriptional regulation of HbF expression.

Lyubomira Chakalova1, Cameron S Osborne, Yan-Feng Dai, Beatriz Goyenechea, Anna Metaxotou-Mavromati, Antonios Kattamis, Christos Kattamis, Peter Fraser.   

Abstract

The 7.2 kilobase (kb) Corfu deltabeta thalassemia mutation is the smallest known deletion encompassing a region upstream of the human delta gene that has been suggested to account for the vastly different phenotypes in hereditary persistence of fetal hemoglobin (HPFH) versus beta thalassemia. Fetal hemoglobin (HbF) expression in Corfu heterozygotes and homozygotes is paradoxically dissimilar, suggesting conflicting theories as to the function of the region on globin gene regulation. Here, we measure gamma- and beta-globin gene transcription, steady-state mRNA, and hemoglobin expression levels in primary erythroid cells cultured from several patients with Corfu deltabeta thalassemia. We show through RNA fluorescence in situ hybridization that the Corfu deletion results in high-level transcription of the fetal gamma genes in cis with a concomitant reduction in transcription of the downstream beta gene. Surprisingly, we find that elevated gamma gene transcription does not always result in a corresponding accumulation of gamma mRNA or fetal hemoglobin, indicating a post-transcriptional regulation of gamma gene expression. The data suggest that efficient gamma mRNA accumulation and HbF expression are blocked until beta mRNA levels fall below a critical threshold. These results explain the Corfu paradox and show that the deleted region harbors a critical element that functions in the developmentally regulated transcription of the beta-globin genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15536151     DOI: 10.1182/blood-2003-11-4069

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

Review 1.  Organization of transcription.

Authors:  Lyubomira Chakalova; Peter Fraser
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-07-28       Impact factor: 10.005

2.  Understanding globin regulation in beta-thalassemia: it's as simple as alpha, beta, gamma, delta.

Authors:  Arthur Bank
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

Review 3.  Regulation of human fetal hemoglobin: new players, new complexities.

Authors:  Arthur Bank
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

4.  Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping interactions between genomic elements.

Authors:  Josée Dostie; Todd A Richmond; Ramy A Arnaout; Rebecca R Selzer; William L Lee; Tracey A Honan; Eric D Rubio; Anton Krumm; Justin Lamb; Chad Nusbaum; Roland D Green; Job Dekker
Journal:  Genome Res       Date:  2006-09-05       Impact factor: 9.043

5.  Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin.

Authors:  Tamara I Pestina; Phillip W Hargrove; Dennis Jay; John T Gray; Kelli M Boyd; Derek A Persons
Journal:  Mol Ther       Date:  2008-12-02       Impact factor: 11.454

Review 6.  Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities.

Authors:  Andrew Wilber; Arthur W Nienhuis; Derek A Persons
Journal:  Blood       Date:  2011-02-14       Impact factor: 22.113

Review 7.  Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents.

Authors:  Alawi H Habara; Elmutaz M Shaikho; Martin H Steinberg
Journal:  Am J Hematol       Date:  2017-08-17       Impact factor: 10.047

8.  Fetal γ-globin genes are regulated by the BGLT3 long noncoding RNA locus.

Authors:  Maria Soledad Ivaldi; Luis Francisco Diaz; Lyubomira Chakalova; Jongjoo Lee; Ivan Krivega; Ann Dean
Journal:  Blood       Date:  2018-08-27       Impact factor: 22.113

9.  The switch from fetal to adult hemoglobin.

Authors:  Vijay G Sankaran; Stuart H Orkin
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

Review 10.  Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders.

Authors:  Daniel E Bauer; Sophia C Kamran; Stuart H Orkin
Journal:  Blood       Date:  2012-08-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.